Aventis Pharma Articles
NICE recommends Sanofi's obesity drug Acomplia
30 June 2008
Sanofi receives FDA license for Pentacel
30 June 2008
Sanofi donates 60M doses of H5N1 vacc
23 June 2008
Stock Commentary - Europe - week to June 16, 2008
23 June 2008
Indian drugmakers may need to hike prices
23 June 2008
Sanofi bids $2.55B for remaining Zentiva stock
23 June 2008
Hybrigenics raises dosage in inecalcitol study
23 June 2008
Staff cuts at GSK and Sanofi-Aventis
16 June 2008
Retail drug sales in year to March 2008
16 June 2008
66% of Lantus patients meet ADA's 7% target
16 June 2008
Trovax yields median PFS of 3.4 months
16 June 2008
Rivaroxaban beats Lovenox: RECORD4 trial
16 June 2008
Spanish pharma market growth 8%
16 June 2008
Stock Commentary - Europe - week to June 2, 2008
9 June 2008
Acomplia linked to five deaths since UK launch
9 June 2008
Bayer's Xarelto wins out in study
9 June 2008
EC targets Sanofi for "obstruction"
9 June 2008
Sanofi-Aventis to sue Cimex over generic Plavix
2 June 2008
Big patent decisions on Lovenox and Lipitor
2 June 2008
GSK names new president
2 June 2008
Multaq reduces severe CV complications 24%
2 June 2008
Aflibercept: strong Ph II data in ovarian cancer
2 June 2008
US Federal Court denies Sanofi-Aventis
19 May 2008
Stock Commentary - Europe - week to May 12, 2008
19 May 2008
Retail drug sales in year to February 2008
19 May 2008
Wal-Mart price war aimed at PBMs
19 May 2008
RotaTeq "100% effective from first dose"
19 May 2008
Novartis vacc beats Menactra in Ph III trials
12 May 2008
ARB switching strategy may not result in long-term savings within a five-year model, says Merck & Co
12 May 2008
Japan stock market week to Apr 28, 2008
5 May 2008
Teva reveals Copaxone sales
5 May 2008
Thai dispute over PReMA member for GPO board
5 May 2008
Sanofi-Aventis
5 May 2008
DNDi in "patent-free" antimalarial drug deal
5 May 2008
GSK in cliffhanger on vacc reimbursement
5 May 2008
B-MS restructure cuts into 1st-qtr profit
5 May 2008
Japan stock market week to Aril 21, 2008
28 April 2008
China denies heparin contamination
28 April 2008
Sanofi puts C$100M into facility in Canada
21 April 2008
Retail drug sales in year to January 2008
21 April 2008
Patients should be told cost of drugs, says US ASCO
14 April 2008
Spiriva and Micardis boost Boehringer's 2007 sales 8.8%, as profit jumps 4.8% to $2.8M
14 April 2008
Japanese drug firms adapting for growth
14 April 2008
Japan stock market week to April 7, 2008
14 April 2008
Sanofi stops marketing Teva's Copaxone in USA
7 April 2008
Stock Commentary - Europe - week to Mach 31, 2008
7 April 2008
Sanofi restructures at Vitry, with job losses
7 April 2008
Taranabant: double the weight loss of placebo
7 April 2008
Sanofi licenses Acambis vacc in more territories
7 April 2008
EC approves Boeh Ing's Pradaxa in VTE
7 April 2008
NICE backs Sanofi's Acomplia for obesity
7 April 2008
Sanofi-Aventis to help market Lilly's Cialis in USA
31 March 2008
Cost-cutting by drugmakers in Germany
31 March 2008
Thailand's GPO: CVD and ARV copycats plan
31 March 2008
US House C'tee declines to press contempt charge
31 March 2008
Belgium's drugmakers welcome 26 new drugs
31 March 2008
11 defendants settle US AWP litigation
24 March 2008
Stock Commentary - Europe - week to March 17, 2008
24 March 2008
Drug industry in 2020, at Economist
17 March 2008
Thiakis' obesity drug enters first clinical trial
17 March 2008
Oxford BioMedica's 2007 loss down 6%
17 March 2008
Oxford BioMedica recruits Ph III Trovax trial
17 March 2008
CHMP approves new 300mg loading dose tablet of Plavix
10 March 2008
Danish gov approves free HPV vaccination
10 March 2008
Stock Commentary - Europe - week to March 3, 2008
10 March 2008
Japan stock market week to Mar 3, 2008
10 March 2008
Sciele and Sanofi extend Allergra accord
10 March 2008
Pharmacopeia intitiates Ph IIb trial of DARA drug
10 March 2008
Artemisinin pact for OneWorld/Sanofi/Amyris
10 March 2008
LEEM marks first European Rare Diseases Day
10 March 2008
Small generic firms struggle in France
3 March 2008
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
